Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT01444742 · COMPLETED
Trial details
- NCT number
- NCT01444742
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-16
- Primary completion
- 2017-01-29
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.